Medherant @BioEurope 2015
Medherant had a very successful trip to BioEurope in Munich on the 2-4 November. Whilst there we gave a short pitch in the Emerging Technologies Forum to introduce the Medherant technology platform and to showcase our early results in the devel...
Medherant Signs License Agreement With Bostik And Secures Seed Investment From Mercia For Development Of Next Generation Transdermal Drug Delivery Systems
New bio-adhesive company Medherant, founded by Warwick Ventures for the University of Warwick, UK, in 2014, has signed a license agreement with the leading global adhesive specialists Bostik. The partnership will supplement Medherant's capabilities t...